The Impact of Baseline Risk Factors on the Incidence of Febrile Neutropenia in Breast Cancer Patients Receiving Chemotherapy with Pegfilgrastim Prophylaxis: A Real-World Data Analysis

The Impact of Baseline Risk Factors on the Incidence of Febrile Neutropenia in Breast Cancer Patients Receiving Chemotherapy with Pegfilgrastim Prophylaxis: A Real-World Data Analysis

Show other versions (1)

**Background:** There are sparse data addressing whether standard risk factors for febrile neutropenia (FN) are relevant in patients receiving myelosuppressive chemotherapy and primary prophylaxis for FN, which would have implications for variables to consider during real-world comparative analyses...

Deskribapen osoa

Xehetasun bibliografikoak
Egile Nagusiak: Edward Li, Bridgette Kanz Schroader, David Campbell, Kim Campbell, Weijia Wang
Formatua: Artikulua
Hizkuntza:English
Argitaratua: Columbia Data Analytics, LLC 2021-06-01
Saila:Journal of Health Economics and Outcomes Research
Sarrera elektronikoa:https://jheor.scholasticahq.com/article/24564-the-impact-of-baseline-risk-factors-on-the-incidence-of-febrile-neutropenia-in-breast-cancer-patients-receiving-chemotherapy-with-pegfilgrastim-prophy.pdf

Antzeko izenburuak

Antzeko izenburuak